204 related articles for article (PubMed ID: 21200181)
1. Beyond the target pathogen: ecological effects of the hospital formulary.
Goldstein EJ
Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S21-31. PubMed ID: 21200181
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial stewardship: bridging the gap between quality care and cost.
Goff DA
Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
[TBL] [Abstract][Full Text] [Related]
3. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
Dinubile MJ; Friedland I; Chan CY; Motyl MR; Giezek H; Shivaprakash M; Weinstein RA; Quinn JP
Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):443-9. PubMed ID: 15990986
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
5. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
8. Current challenges in the management of the infected patient.
Nicolau DP
Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S1-10. PubMed ID: 21200179
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
10. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.
Carmeli Y; Lidji SK; Shabtai E; Navon-Venezia S; Schwaber MJ
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):367-72. PubMed ID: 21683268
[TBL] [Abstract][Full Text] [Related]
11. Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary.
Graber CJ; Hutchings C; Dong F; Lee W; Chung JK; Tran T
Epidemiol Infect; 2012 Jan; 140(1):115-25. PubMed ID: 21303590
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial stewardship and Clostridium difficile-associated diarrhea.
Piacenti FJ; Leuthner KD
J Pharm Pract; 2013 Oct; 26(5):506-13. PubMed ID: 23946208
[TBL] [Abstract][Full Text] [Related]
13. [Proper antibiotic therapy. From penicillin to pharmacogenomic].
Caramia G; Ruffini E
Minerva Pediatr; 2012 Apr; 64(2):225-37. PubMed ID: 22495196
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial stewardship.
Fishman N
Am J Med; 2006 Jun; 119(6 Suppl 1):S53-61; discussion S62-70. PubMed ID: 16735152
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the emergence of bacterial resistance in the hospital environment.
Hosein IK; Hill DW; Jenkins LE; Magee JT
J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
[TBL] [Abstract][Full Text] [Related]
16. [Collateral damage and hospital infections].
Vrbić M; Vrbić B; Velicković-Radovanovanović R; Mitić R; Doder R
Med Pregl; 2010; 63 Suppl 1():47-51. PubMed ID: 21438204
[TBL] [Abstract][Full Text] [Related]
17. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Joseph J; Rodvold KA
Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
[TBL] [Abstract][Full Text] [Related]
18. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
[TBL] [Abstract][Full Text] [Related]
19. At least it won't hurt: the personal risks of antibiotic exposure.
Stewardson AJ; Huttner B; Harbarth S
Curr Opin Pharmacol; 2011 Oct; 11(5):446-52. PubMed ID: 21775205
[TBL] [Abstract][Full Text] [Related]
20. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
